Background: Carbonic anhydrase II (CAII) augments activity of monocarboxylate transporters (MCTs) by noncatalytic interaction. Results: CAII binds to an acidic cluster with an appropriate context in the MCT C terminus. Conclusion: Isoform-specific interaction between MCTs and CAII requires a specific binding moiety. Significance: CAII-mediated increase in lactate transport depends on the presence of a specific binding moiety in MCT.
MCT1 and MCT4 is mediated by a histidine residue at position 64. Taken together, our results suggest that facilitation of MCT transport activity by CAII requires direct binding between histidine 64 in CAII and a cluster of glutamic acid residues in the C terminus of the transporter that has to be positioned in surroundings that allow access to CAII.
The SLC16 gene family of monocarboxylate transporters (MCTs) 2 comprises 14 isoforms, the first four of which carry high energy metabolites, such as lactate, pyruvate, and ketone bodies together with H ϩ in a 1:1 stoichiometry (1-5). MCT1 is found in nearly all tissues, where it operates either as a lactate importer or exporter (3) (4) (5) . MCT1 has an intermediate K m value of 3-5 mM for L-lactate (1, 2) . MCT2, which is primarily found in liver, kidney, testis, and brain (6 -8) , has the highest affinity for L-lactate among all MCTs with a K m value of ϳ0.7 mM (9) . In liver and kidney, MCT2 facilitates the uptake of lactate, which is used for glyconeogenesis in these tissues (3) . In the brain, MCT2 is expressed in neurons, where it facilitates the import of lactate, which is exported from astrocytes and vascular endothelial cells via MCT1 and MCT4 (10 -13) . Expression of MCT3 is restricted to retinal pigment epithelium and choroid plexus epithelia, where it primarily serves as a lactate exporter (14 -16) . MCT3 transports L-lactate with a K m of ϳ6 mM (17) . MCT4 is a low affinity, high capacity carrier with a K m value of 20 -35 mM for L-lactate (18) . It primarily acts as a lactate exporter in glycolytic cells and tissues like astrocytes, skeletal muscle, and (hypoxic) tumor cells (3, 5, 19, 20) . All MCTs have a 12-transmembrane helix structure, with both the C and N termini located intracellularly (3, 5) . Trafficking, but also regulation of transport activity of MCT1-4, is mediated by ancillary proteins. MCT1 and MCT4 are associated with basigin (CD147), whereas surface expression and transport activity of MCT2 is facilitated by embigin (GP70) (21, 22) .
Mammalian carbonic anhydrases (CA), included in the ␣-class of CAs, of which 16 isoforms are identified, catalyze the reversible hydration of CO 2 to HCO 3 Ϫ and H ϩ (23, 24) . Cytosolic CAII has been found to bind to and facilitate transport function of many acid/base transporting membrane proteins, including the Cl Ϫ /HCO 3 Ϫ exchangers AE1 and AE2 (25) (26) (27) (28) (29) , the Na ϩ /HCO 3 Ϫ cotransporters NBCe1 and NBCn1 (30 -36 ) and the Na ϩ /H ϩ exchanger NHE1 (37, 38) , a phenomenon coined "transport metabolon." In all cases, CAII was found to bind to an acidic cluster within the C-terminal tail of the transport protein. In AE1, 886 LDADD was identified as CAII binding site (27, 28) , whereas binding of CAII to AE2 requires the corresponding cluster 1216 LDANE (27) . In NBCe1, the acidic clusters 958 LDDV and 986 DNDD are suggested to bind CAII (33, 34) , and in NBCn1, binding to CAII is mediated by Asp 1135 and Asp 1136 (35) . Binding of CAII to NHE1 involves the penultimate group of 13 amino acids of the transporter C terminus ( 790 RIQRCLSDPGPHP), with the amino acids Ser 796 and Asp 797 playing an essential role in the binding (37, 38) . For a more comprehensive review on bicarbonate transport metabolons see Refs. 39 -41. Using heterologous protein expression in Xenopus oocytes, we have recently reported that CAII enhances transport activity of MCT1 and MCT4, while leaving transport activity of MCT2 unaffected (42) (43) (44) (45) (46) . In contrast to the transport metabolons described so far, this interaction is independent of CAII catalytic activity but is mediated by an intramolecular H ϩ shuttle within the enzyme (47, 48) . This led to the conclusion that CAII, directly bound to the transporter, can act as a H ϩ -collecting/distributing antenna, which shuttles protons between transporter and surrounding protonatable residues to support proton/lactate cotransport (48) . By introduction of single-site mutations in the C terminus of MCT1 and subsequent expression of these mutants in CAII-injected Xenopus oocytes, we could identify the two glutamic acidic residues Glu 489 and Glu
491
, flanking the cluster 489 EEE within the MCT1 C terminus, to be crucial for the functional interaction with CAII (49). In the same study, a direct binding between CAII and a GST fusion protein of the MCT1 C terminus could be shown by coimmunoprecipitation when the acidic cluster 489 EEE was intact, whereas mutation of Glu 489 and/or Glu 491 suppressed binding between MCT1-CT and CAII. This suggests that cytosolic CAII can bind to the C terminus of MCT1, which presumably positions the enzyme close enough to the pore of the transporter for efficient H ϩ shuttling. In the present study, we could demonstrate that introduction of a CAII binding site into the C terminus of MCT2 induced CAII-mediated facilitation of MCT2 transport activity. However, binding and functional interaction between MCT2 and CAII could only be achieved when the two glutamic acid residues mediating binding to CAII were located in a moiety that allowed their access to the enzyme. This demonstrates that the sole presence of an acidic amino acid cluster within the C terminus of a transport protein is not sufficient to mediate binding of CAII to this transporter but that the amino acid environment needs to allow free access of the binding site to CAII 
EXPERIMENTAL PROCEDURES
Site-directed Mutation of MCT2 and MCT4 -Site-directed mutation of MCT2 and MCT4 was carried out by PCR using a mix of Taq and Pfu polymerases (Fermentas high fidelity PCR enzyme mix; Thermo Fisher) and modified primers, which contained the desired mutation. Primers used for creation of the different mutants are shown in Table 1 . Rat MCT2 and MCT4, cloned in the oocyte expression vector pGEM-He-Juel (9, 18), were used as template. PCR was cleaned up using the Gene Jet plasmid miniprep kit (Thermo Fisher), and the template was digested with DpnI (Fermentas FastDigest DpnI; Thermo Fisher) before transformation into Escherichia coli DH5␣ cells.
Pulldown of CAII with GST Fusion Proteins-C termini of rat MCT1-WT, rat MCT2-WT, rat MCT4-WT, and mutants of the C termini were cloned into the expression vector pGEX-2T (GE Healthcare Europe GmbH) and transformed into E. coli BL21 cells. Protein expression was induced by addition of 0.8 mM isopropyl-␤-D-thiogalactopyranoside. 3 h after induction, the cells were harvested and resuspended in PBS and lysed with lysis buffer (PBS, 2 mM MgCl 2 , 1% Triton X-100) in the presence of protease inhibitors (protease inhibitor mixture tablets; Roche). Bacterial lysates were centrifuged for 15 min at 4°C at 12,000 ϫ g, and the supernatant containing the GST fusion protein (bait protein) was collected for further use. CAII-WT and CAII-H64A, respectively, were expressed in Xenopus oocytes, as described in the next section. For each experiment, 25 oocytes were lysed in lysis buffer in the presence of protease inhibitors (Roche). Oocyte lysates were centrifuged for 15 min at 4°C at 12,000 ϫ g, and the supernatant (prey protein) was collected for further use.
The pulldown experiment was carried out using the Pierce GST protein interaction pulldown kit (Thermo Fisher). Briefly, for immobilization of GST fusion protein, 400 g of bacterial lysate was added to a column containing 50 l of 50% slurry of glutathione agarose and incubated for 2 h at 4°C with end over 
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Binding between MCTs and CAII FEBRUARY 13, 2015 • VOLUME 290 • NUMBER 7 end mixing. After incubation, the excess bait protein was removed by centrifugation (4°C, 700 ϫ g), and the beads were washed five times with wash buffer (1 PBS: 1 lysis buffer). 400 l of oocyte lysate containing CAII-WT or CAII-H64A was added to the column and incubated for 2 h at 4°C with end over end mixing. After incubation, the excess prey protein was removed by centrifugation (4°C, 700 ϫ g), and the beads were washed five times with wash buffer. Protein was eluted from the beads with 250 l of elution buffer (10 mM glutathione in PBS, pH 8.0). To determine the relative amount of GST and CAII, an equal volume of the samples was analyzed by Western blotting. GST was detected using a primary anti-GST antibody (dilution 1:400, anti-GST tag mouse monoclonal IgG, no. 05-782; Millipore) and a goat anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (dilution 1:12000; Santa Cruz). CAII was detected using a primary anti-CAII antibody (human erythrocytes) (dilution 1:400, rabbit anti-carbonic anhydrase II polyclonal antibody, AB1828; Millipore) and a goat anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (dilution 1:12000; Santa Cruz). Membranes were analyzed after incubation with Luminata classic Western HRP substrate (Millipore) with an Odyssey Fc dual mode imaging system (Li-Cor Biosciences). Quantification of the band intensity was carried out with the software ImageJ. To overcome variations in the signal intensity between different blots, the signal intensity of each band for CAII was normalized to the signal intensity of the band from the pulldown of CAII with the GST fusion protein of the full-length C terminus. To account for variations in the amount of GST fusion protein, each normalized signal for CAII was divided by the corresponding, normalized signal for GST.
Heterologous Protein Expression in Xenopus Oocytes-Plasmid DNA of rat MCT1-WT, rat MCT2-WT, rat MCT4-WT, rat GP70, human CAII-WT, and mutants of the proteins, respectively, cloned into the oocyte expression vector pGEMHe-Juel, which contains the 5Ј and the 3Ј untranscribed regions of the Xenopus ␤-globin flanking the multiple cloning site, was linearized with SalI (Fermentas FastDigest SalI; Thermo Fisher) and transcribed in vitro with T7 RNA polymerase (Ambion mMessage mMachine; Life Technologies) as described earlier (50) . Xenopus laevis females were purchased from Xenopus Express (Vernassal, France). Segments of ovarian lobules were surgically removed under sterile conditions from frogs anesthetized with 1 g/liter of 3-amino-benzoic acid ethylester (MS-222; Sigma-Aldrich) and rendered hypothermic. The procedure was approved by the Landesuntersuchungsamt Rheinland-Pfalz, Koblenz (23 177-07/A07-2-003 §6). Oocytes were singularized by collagenase (collagenase A; Roche) treatment and stored overnight in oocyte saline (82.5 mM NaCl, 2.5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM Na 2 HPO 4 , 5 mM HEPES), supplemented with gentamycin at 18°C to recover. To investigate the influence of CAII on transport activity of MCT2 and MCT4, oocytes of the stages V and VI were injected with 5 ng of cRNA coding for MCT2-WT (ϩ10 ng of GP70), MCT4-WT, or a mutant of the proteins, 3-6 days before the experiment, using a microinjection system (WPI Nanoliter 2000; World Precision Instruments Germany). Bovine CAII protein (C3934; SigmaAldrich) was injected in a concentration of 50 ng/oocyte 1 day before measurement. To investigate the influence of CAII mutants on MCT1 transport activity, oocytes were coinjected with 5 ng of cRNA coding for MCT1 and 12 ng of cRNA coding for CAII-WT or a CAII mutant, 3-6 days before the experiment.
Measurement of Intracellular H ϩ Concentration in Xenopus Oocytes-All measurements were carried out in HEPES-buffered solution (82.5 mM NaCl, 2.5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM Na 2 HPO 4 , 5 mM HEPES). In lactate-containing saline, NaCl was replaced by an equivalent amount of sodium L-lactate. Application of lactate was always carried out in HEPES-buffered solution at pH 7.0, in the nominal absence of CO 2 /HCO 3 Ϫ , containing ϳ0.008 mM of CO 2 from air and hence a HCO 3 Ϫ concentration of less than 0.2 mM. To check for CAII catalytic activity, a short CO 2 pulse was applied. For this solution, NaCl was replaced by 10 mM NaHCO 3 , and the solution was aerated with 5% CO 2 /95% O 2 .
For measurement of intracellular H ϩ concentration and membrane potential, single-barreled microelectrodes were used; the manufacture and application have been described in detail previously (51, 52) . Briefly, a borosilicate glass capillary of 1.5 mm in diameter was pulled to a micropipette and was silanized with a drop of 5% tri-N-butylchlorsilane in 99.9% pure carbon tetrachloride, backfilled into the tip. The micropipette was baked for 4.5 min at 450°C on a hot plate. H ϩ -sensitive mixture (no. 95291; Fluka) was backfilled into the silanized tip and filled up with 0.1 sodium citrate, pH 6.0. To increase the opening of the electrode tip, it was beveled with a jet stream of aluminum powder suspended in H 2 O. The reference electrode was filled with 3 M KCl. Calibration of the electrodes was carried out in oocyte salines with a pH of 7.0 and 6.4. As described previously (2), optimal pH changes were detected when the electrode was located near the inner surface of the plasma membrane. During all measurements, the oocytes were clamped to a holding potential of Ϫ40 mV using an additional microelectrode, filled with 3 M KCl, and connected to an Axoclamp 2B amplifier (Axon Instruments). All experiments were carried out at room temperature (22-25°C). The measurements were stored digitally using custom made PC software based on the program LabView (National Instruments). The rate of change of the measured [H ϩ ] i was analyzed by determining the slope of a linear regression fit using the spreadsheet program OriginPro 8.6 (OriginLab Corporation). Conversion and analysis of the data has been described in detail previously (52) .
Calculation and Statistics-Statistical values are presented as means Ϯ S.E. of the mean. For calculation of significance in differences, Student's t test or, if possible, a paired t test was used. In the figures shown, a significance level of p Յ 0.05 is marked with *, p Յ 0.01 is marked with **, and p Յ 0.001 is marked with ***.
Structural Model of the Binding between MCT1/MCT4 and CAII-The C terminus of MCT1 is predicted to be intrinsically disordered but may adapt secondary structure upon binding CAII and was therefore modeled to form a distorted helix turn helix motif using a leucine zipper (Protein Data Bank code 1A93) as a starting model to facilitate binding to the slightly acidic and hydrophobic faces of CAII. The C terminus of MCT4 is based on the model of the MCT1 C terminus, with minor rearrangements to facilitate proper CAII-His 64 interactions. CAII is based on the crystal structure of human CAII (Protein Data Bank code 2ILI (53)). Models were created utilizing SWISS Model. Docking of the C terminus of MCT1/MCT4 to CAII was performed using the interactive software COOT (54) and then energy minimizing using the program CNS (55).
Graphical representations of the structures were created with MacPyMOL (DeLano Scientific LLC). Ϫ . E, representative Western blots of CAII (upper blot) and GST (lower blot), respectively. CAII was pulled down with GST, a GST fusion protein of the C terminus of MCT1-WT, MCT2-WT, or a GST fusion protein of a mutant of the MCT2-CT. F, relative intensity of the fluorescent signal of CAII. For every blot, the signals for CAII were normalized to the corresponding signals for GST-MCT1-WT. Each individual signal for CAII was normalized to the intensity of the signal for GST. The asterisks above the bars refer to GST-MCT2-WT. n is given as the number of Western blots/number of pulldown experiments.
RESULTS
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Although the C terminus of MCT1 contains a CAII binding site ( 489 EEE), MCT2 lacks such a cluster (Fig. 1A) . To test the hypothesis that the failure of CAII to enhance MCT2 transport activity is due to the lack of an appropriate CAII-binding site in the MCT2-C terminus, we introduced a putative CAII-binding site into the C terminus of MCT2. Therefore we replaced lysine 485 and serine 487 by glutamate (MCT2-K485E/S487E), which would create a putative CAII-binding site ( 485 EEE) at a similar position as found in MCT1 ( 489 EEE). MCT2-WT and MCT2-K485E/S487E, respectively, were coexpressed together with their chaperone embigin (GP70) in Xenopus oocytes, either with or without 50 ng CAII protein injected. MCT2 transport activity was determined by measuring the rate of rise in intracellular
] i /⌬t) during application of 0.3, 1, and 3 mM lactate, respectively, in HEPES-buffered, nominal CO 2 /HCO 3 Ϫ -free solution (Fig. 1, B and D) . Injection of CAII did not result in an increase in MCT2 transport function, neither in MCT2-WT nor in MCT2-K485E/S487E, carrying the putative CAII binding site (Fig. 1B) . However, in MCT2-K485E/S487E the putative binding site 485 EEE is surrounded by polar or bulky amino acids (see inset in Fig. 1B ) that are not found at this position in MCT1. To determine whether these amino acids might obscure the CAII-binding site, we exchanged the seven most distal amino acids in the MCT2 C terminus to the corresponding amino acids of the MCT1 C terminus (R483P/D484A/K485E/E486E/S487E/S488S/I489P, MCT2-PAEEESP) and coexpressed the mutant with embigin in Xenopus oocytes. Indeed, injection of CAII increased transport activity of MCT2-PAEEESP by a factor of ϳ2, indicating a functional interaction between CAII and the MCT2 mutant (Fig.  1B) . Catalytic activity of CAII was controlled in each oocyte by measuring ⌬[H ϩ ] i /⌬t during application of 5% CO 2 , 10 mM HCO 3 Ϫ at the end of the experiment (Fig. 1D ) to confirm successful injection of CAII. In all three batches of oocytes, injection of CAII increased the rate of CO 2 -induced acidification by a factor of ϳ6.5 with no significant difference between the batches (Fig. 1C) .
Binding between CAII and MCT2 was tested by pulldown of CAII with GST fusion proteins of the C termini of MCT2-WT, MCT2-K485E/S487E, and MCT2-PAEEESP, respectively (Fig.  1E) . A GST fusion protein of the C terminus of MCT1 was used as positive control. To overcome variations in the signal intensity between different blots, signal intensity of each band for CAII was normalized to the signal intensity of the band from the pulldown of CAII with GST-MCT1-WT. To account for variations in the amount of GST fusion protein, each normalized signal for CAII was divided by the corresponding, normalized signal for GST. Pulldown of CAII with GST-MCT2-WT resulted in a very weak signal for CAII (Fig. 1F) . Mutation of Lys 485 and Ser 487 to glutamic acid (GST-MCT2-K485E/S487E) did not increase the amount of captured CAII, whereas mutation of the last seven amino acids of the MCT2 C terminus to the corresponding amino acids in MCT1 (GST-MCT2-PAEEESP) resulted in a significant increase in the amount of captured CAII, which indicates direct binding of CAII to MCT2-PAEEESP. These data indicate that the mere presence of an appropriate acidic amino acid cluster within the C terminus of the transport protein is not sufficient to mediate binding of CAII but that the amino acids surrounding this acidic cluster must allow free access of the binding site to CAII.
CAII-mediated Augmentation of MCT4 Transport Activity Requires Physical Interaction between CAII and the MCT4 C Terminus-In MCT1, binding to CAII is mediated by the two glutamic acid residues Glu
489 and Glu 491 in the C terminus of the transporter ( Fig. 2A) , which is mandatory for the CAIImediated augmentation in MCT1 transport activity (49) . The C terminus of rat MCT4 contains three similar clusters in which two glutamic acid residues are separated by one amino acid: 431 EEE, 448 EVE, and 456 EPE (Fig. 2, A and F) . To analyze which one of these three clusters is required for the functional interaction between MCT4 and CAII, we created two truncation mutants of MCT4, missing either all three potential binding sites (MCT4-S430X) (Fig. 2B) . Injection of CAII enhanced transport activity of MCT4-WT by a factor of ϳ2, as determined by ⌬[H ϩ ] i /⌬t during application of lactate (Fig. 2C) . Truncation of the MCT4 C terminus at position 430 (MCT4-S430X; removal of all three potential binding sites) resulted in a complete loss of the CAII-mediated augmentation in MCT4 transport activity (Fig. 2C) . In contrast, truncation of the MCT4 C terminus at position 446 (MCT4-S446X; removal of 448 EVE and 456 EPE) had no effect on the CAII-induced augmentation in MCT4 transport activity (Fig. 2C) . Transport activity of MCT4 itself in the absence of CAII was not altered by truncation of the C terminus (Fig. 2C, gray bars) . These data indicate that functional interaction between MCT4 and CAII is mediated by an amino acid cluster located between Ser 430 and Ser 446 in the MCT4 C terminus, most likely the glutamic acid cluster 431 EEE. To further analyze which glutamic acid residues within this cluster are required for functional interaction between MCT4 and CAII, we replaced the three glutamic acid residues Glu 431 -Glu 433 by glutamine in any possible combination and expressed the mutants in Xenopus oocytes with and without CAII (Fig. 2,  D and E) . Single replacement of any glutamic acid residue by glutamine (MCT4-E431Q, MCT4-E432Q, and MCT4-E433Q, respectively) had no effect on the CAII-mediated augmentation in MCT4 transport activity. Injection of CAII induced an increase in ⌬[H ϩ ] i /⌬t by a factor of ϳ2 in all mutants, as observed for MCT4-WT (Fig. 2D) . However, simultaneous replacement of all three glutamic acid residues by glutamine (MCT4-E431Q/E432Q/E433Q) completely abolished CAII-induced augmentation in MCT4 transport activity (Fig. 2D) . Replacement of the two glutamic acid residues by glutamine at the rim of the cluster (MCT4-E431Q/E433Q) also abolished CAII-induced augmentation in MCT4 transport activity, whereas replacing either one of the flanking glutamic acid residues and the glutamic acid residue in the middle of the cluster by glutamine (MCT4-E431Q/E432Q and MCT4-E432Q/ E433Q, respectively) had no effect on the CAII-induced augmentation in MCT4 activity (Fig. 2E) . These data indicate that at least one of the two glutamic acid residues Glu 431 and Glu 433 in the MCT4 C terminus is required for the functional interaction between MCT4 and CAII. Catalytic activity of CAII was controlled in each oocyte by measuring ⌬[H ϩ ] i /⌬t during application of 5% CO 2 , 10 mM HCO 3 Ϫ at the end of the experiment. To test whether CAII binds to the C terminus of MCT4, we pulled down CAII from lysates of CAII-expressing Xenopus oocytes with GST fusion proteins of the MCT4 C terminus, bound to agarose beads. The amount of captured CAII was quantified by Western blot analysis (Fig. 3A, upper row) . To overcome variations in the signal intensity between different blots, signal intensity of each band for CAII was normalized to the signal intensity of the band from the pulldown of CAII with GST-MCT4-WT. To account for variations in the amount of GST fusion protein, each normalized signal for CAII was divided by the corresponding, normalized signal for GST. Pulldown of CAII with a GST fusion protein of the full-length C terminus of MCT4 (GST-MCT4-WT) resulted in a robust signal for CAII on the Western blot, whereas pulldown of CAII with GST alone resulted in almost no signal for CAII (3.0 Ϯ 1.6% of the signal achieved with GST-MCT4-WT), indicating direct binding of CAII to the C terminus of MCT4, but not to Binding between MCTs and CAII FEBRUARY 13, 2015 • VOLUME 290 • NUMBER 7 GST (Fig. 3B) . Truncation of the C terminus at position 430 (GST-MCT4-S430X) resulted in vast reduction of the signal to 4.8 Ϯ 1.5% (as compared with GST-MCT4-WT), whereas truncation at position 446 (GST-MCT4-S446X) had no significant effect on the amount of captured CAII (Fig. 3B) . Single replacement of any glutamic acid residue by glutamine (GST-MCT4-E431Q, GST-MCT4-E432Q, and GST-MCT4-E433Q, respectively), as well as replacing either one of the flanking glutamic acid residues and the glutamic acid residue in the middle of the cluster by glutamine (GST-MCT4-E431Q/E432Q and GST-MCT4-E432Q/E433Q, respectively) also showed no significant effect on the amount of precipitated CAII (Fig. 3B) . In contrast to that, replacement of the two glutamic acid residues at the rim of the cluster by glutamine (GST-MCT4-E431Q/E433Q), as well as simultaneous replacement of all three glutamic acid residues by glutamine (GST-MCT4-E431Q/E432Q/E433Q), led to a significant reduction in the amount of captured CAII (Fig.   3B ). These data indicate that CAII binds to the C terminus of MCT4 and that at least one of the two glutamic acid residues Glu 431 and Glu 433 within the MCT4 C terminus is required for the binding.
Assuming that a CAII-binding site in MCT4 should be conserved along different mammalian species, we aligned the protein sequence of the MCT4 C terminus of the five mammalian species analyzed so far (Fig. 3C) ated facilitation of transport activity (48) . To test whether binding between MCT1/4 and CAII is mediated by His 64 in CAII, we pulled down CAII-WT or CAII-H64A with GST-MCT1 and GST-MCT4, respectively (Fig. 4A) . Although pulldown of CAII-WT with GST-MCT1 and GST-MCT4 resulted in a robust signal for CAII, virtually no signal could be detected when CAII-H64A was pulled down with GST-MCT1 or GST-MCT4 (Fig. 4B) . To make sure that the antibody used for detection of CAII in the pulldown experiment is able to recognize CAII-H64A, we directly blotted lysates of Xenopus oocytes expressing CAII-WT and CAII-H64A, respectively, and stained for CAII using the same antibody as used for CAII detection after the pulldown (Fig. 4C) . The plot showed robust signals both for CAII-WT and CAII-H64A, indicating that CAII-H64A can be recognized by the antibody. These results indicate that binding of MCT1 and MCT4 to CAII is likely mediated by CAII-His 64 .
DISCUSSION
The present study shows that introduction of a CAII-binding site into the C terminus of MCT2 induces CAII-mediated augmentation in MCT2 activity. However, binding and functional interaction could only be achieved when the ambient amino acids were arranged in a fashion that allowed access of the introduced binding site to CAII.
We have previously shown that CAII facilitates transport activity of MCT1, but not MCT2, when the proteins are heterologously expressed in Xenopus oocytes (42, 43, (45) (46) (47) (48) (49) . Facilitation of MCT1 transport function has been found to be independent of the catalytic activity of the enzyme (42, 43) but required both the intramolecular H ϩ shuttle of CAII (CAIIHis 64 ) (48) and the CAII-binding site 489 EEE in the C terminus of MCT1 (49) . This led to the conclusion that CAII, directly bound to the transporter, can act as a H ϩ -collecting/distributing antenna, which shuttles protons between transporter and surrounding protonatable residues to support proton/lactate cotransport (48) . The requirement for H ϩ -collecting antennae has been proposed for H ϩ cotransporters such as MCTs, whose substrate is present at very low concentrations (56) . By modeling intracellular diffusion of ions following Brownian movement, the authors found that transporters that utilize substrates like Ca 2ϩ or H ϩ , which are available in the cell only at very low concentrations, show experimental rates of transport that are considerably faster than the rates at which the aqueous phase may possibly feed their binding sites. From this paradoxical finding the authors concluded that Ca 2ϩ and H ϩ transporters do not extract their substrates directly from the bulk cytosol but from an intermediate "harvesting" compartment located between the aqueous phase and the transport site (56) , which in the case of MCTs might be CAII. An efficient proton transfer requires close proximity between transporter and enzyme. Therefore, the failure of CAII to increase MCT2 transport activity was attributed to the lack of an appropriate CAII binding site in the C terminus of MCT2. Indeed, the present study shows no binding between CAII and the C terminus of MCT2-WT. To investigate whether introduction of a CAII-binding site into the C terminus of MCT2 might induce facilitation of MCT2 transport activity by CAII, we first introduced a cluster of three glutamic acid residues ( 485 EEE) into the C terminus of MCT2. However, although this potential binding cluster was located at the analogous position of the CAII-binding cluster in MCT1 ( 489 EEE), neither binding of MCT2 to CAII nor CAIIinduced facilitation of MCT2 transport activity was observed. Only when the ambient amino acid residues were mutated to the corresponding residues in MCT1 (R483P, D484A, and I489P) was CAII able to bind and facilitate transport activity of MCT2. We speculate that the newly introduced CAII-binding site 485 EEE was either obscured by ambient, bulky amino acids or that binding was suppressed because of electrostatic problems, because in the mutant four instead of three acidic amino acid residues are present in a row (DEEE in MCT2-K485E/ S487E, instead of AEEE in MCT1-WT). Only when these constraints are removed can the MCT C terminus bind to CAIIHis 64 . This leads to the conclusion that the mere presence of an appropriate acidic amino acid cluster within the C terminus of a transport protein is not sufficient to mediate binding of CAII to this transporter, but that amino acids surrounding this acidic cluster must allow free access of the binding site to CAII and hence functional interaction between these proteins.
We further could show that direct binding between MCT4 and CAII-mediated by Glu 431 and Glu 433 in the C terminus of MCT4 and CAII-His 64 is essential for functional interaction between the two proteins. This arrangement is similar to the binding between MCT1-Glu 489 /Glu 491 and CAII-His 64 , which allows CAII-mediated facilitation of MCT1 transport activity. Therefore, it appears likely that CAII has to be recruited to the transporter by direct binding to the C-terminal tail of MCT1/4 to be close enough to the transporter pore to establish a proton shuttle between transporter and surrounding protonable residues. A structural model of the binding of CAII to the C terminus of MCT1 and MCT4, respectively, is shown in Fig. 5 . The eight most distal amino acids of the MCT1 C terminus ( 487 PAEEESPV) fit well into the surface groove of CAII (Fig.  5A) . The side chains of Glu 489 and Glu 491 of the MCT1 C terminus, which have both been shown to be crucial for binding and functional interaction between MCT1 and CAII (49), point toward the CAII interface within hydrogen bond distance from CAII-His 64 in the "out" configuration. In contrast, Glu 490 of MCT1-CT points outward to the bulk solvent and would therefore not be involved in the interaction with CAII (Fig. 5A) . In contrast to MCT1, the C terminus of MCT4 does not fully cover the surface grove of CAII, but only the three glutamic acid residues 431 EEE, which form the CAII binding site, are in close contact with the enzyme (Fig. 5B) . The side chains of Glu 431 and Glu 433 of the MCT4 C terminus, which have both been shown to be crucial for binding and functional interaction between MCT4 and CAII, point toward the CAII interface within hydrogen bond distance from CAII-His 64 in the "out" configuration. In contrast, Glu 432 of MCT4-CT points outward to the bulk solvent and would therefore not be involved in the interaction with CAII (Fig. 5B) .
Although MCT1 and MCT4 each carry a CAII-binding cluster of three glutamic acid residues, in which the two flanking residues are directly involved in binding, several differences between the CAII-binding sites in MCT1 and MCT4 could be observed. Although in MCT1 both flanking glutamic acid residues (Glu 489 and Glu 491 ) are required for binding and functional interaction with CAII (49), only one of the two flanking glutamic acid residues (Glu 431 or Glu 433 ) in the binding cluster of MCT4 is required for physical and functional interaction with CAII (this study). This difference may indicate a stronger binding of CAII to MCT4 than to MCT1. However, without further analysis of the binding kinetics, this assumption remains speculative.
